Editorial: Precision medicine for acute myeloid leukemia

被引:0
|
作者
Marconi, Giovanni [1 ]
Guolo, Fabio [2 ,3 ]
Nanni, Jacopo [4 ]
Papayannidis, Cristina [5 ]
机构
[1] IRCCS Ist Romagnolo Studio Tumori IRST Dino Amador, Meldola, Italy
[2] Univ Genoa, Chair Hematol, Dept Internal Med DiMI, Genoa, Italy
[3] IRCCS Osped Policlin San Martino, Dipartimento Oncol & Ematol DIPOE, Clin Ematol, Genoa, Italy
[4] Univ Bologna, Ist Ematol Seragnoli, Dipartimento Sci Med & Chirurg, Bologna, Italy
[5] IRCCS Azienda Osped Univ Bologna, Ist Ematol Seragnoli, Bologna, Italy
来源
FRONTIERS IN ONCOLOGY | 2023年 / 13卷
关键词
leukemia (acute myeloid); precision medicine; personalized therapy; target agents; new therapeutic agents;
D O I
10.3389/fonc.2023.1233757
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [22] Precision medicine in acute lymphoblastic leukemia
    Ching-Hon Pui
    Frontiers of Medicine, 2020, 14 : 689 - 700
  • [23] A machine learning approach to integrate big data for precision medicine in acute myeloid leukemia
    Lee, Su-In
    Celik, Safiye
    Logsdon, Benjamin A.
    Lundberg, Scott M.
    Martins, Timothy J.
    Oehler, Vivian G.
    Estey, Elihu H.
    Miller, Chris P.
    Chien, Sylvia
    Dai, Jin
    Saxena, Akanksha
    Blau, C. Anthony
    Becker, Pamela S.
    NATURE COMMUNICATIONS, 2018, 9
  • [24] Clinical Correlation of a Precision Medicine Test with Treatment Outcome in Acute Myeloid Leukemia Patients
    Zhu, Hong-Hu
    Ji, Min
    Ji, Chunyan
    Wang, Chongwu
    Ge, Yaqiong
    Zhou, Xiaoping
    Gorrochategui, Julian
    Primo, Daniel
    Ballesteros, Joan
    Li, Li
    Martinez-Lopez, Joaquin
    BLOOD, 2020, 136
  • [25] A machine learning approach to integrate big data for precision medicine in acute myeloid leukemia
    Su-In Lee
    Safiye Celik
    Benjamin A. Logsdon
    Scott M. Lundberg
    Timothy J. Martins
    Vivian G. Oehler
    Elihu H. Estey
    Chris P. Miller
    Sylvia Chien
    Jin Dai
    Akanksha Saxena
    C. Anthony Blau
    Pamela S. Becker
    Nature Communications, 9
  • [26] Acute myeloid leukemia in the era of precision medicine:recent advances in diagnostic classification and risk stratification
    Rina Kansal
    Cancer Biology & Medicine, 2016, (01) : 41 - 54
  • [27] Future perspective: metabolism as a therapeutic target in acute myeloid leukemia - from Warburg to precision medicine
    Hatfield, Kimberley Joanne
    Gronningsaeter, Ida Sofie
    Reikvam, Hakon
    CURRENT MEDICAL RESEARCH AND OPINION, 2021, 37 (12) : 2107 - 2111
  • [28] Evaluation of a Rapid Automated Next Generation Sequencing Assay for Precision Medicine in Acute Myeloid Leukemia
    Andrew, Georgia M.
    Dillon, Laura W.
    Saeed, Maria
    Saeed, Maria
    Chang, Ting-Chia
    Narava, Sikrishna K.
    Mosher, Erin M.
    Majano, Marvin S.
    Lee-Fong, Anna
    Zhang, John N.
    Sedova, Marina
    Huang, Jiajie
    Mittal, Vinay K.
    Hatch, Andrew G.
    Ni, Jingwei
    Kaznadzey, Denis
    Sadis, Seth
    Smith, Jeffery M.
    Little, Richard F.
    Harris, Lyndsay
    Doroshow, James H.
    Williams, P. Mickey
    Jiwani, Shahanawaz
    Houri, Christopher S.
    BLOOD, 2021, 138
  • [29] Acute myeloid leukemia in the era of precision medicine:recent advances in diagnostic classification and risk stratification
    Rina Kansal
    Cancer Biology & Medicine, 2016, 13 (01) : 41 - 54
  • [30] Acute myeloid leukemia in the era of precision medicine: recent advances in diagnostic classification and risk stratification
    Kansal, Rina
    CANCER BIOLOGY & MEDICINE, 2016, 13 (01) : 41 - 54